The smart syringe market size has grown rapidly in recent years. It will grow from $12.15 billion in 2025 to $13.55 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising vaccination programs worldwide, increasing prevalence of chronic diseases, growing awareness of healthcare worker safety, adoption of single-use injection devices, expansion of hospital-based injection procedures.
The smart syringe market size is expected to see rapid growth in the next few years. It will grow to $21.46 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand for smart drug administration devices, rising government mandates for safety syringes, expansion of home-based healthcare delivery, growing focus on digital medication tracking, increasing adoption in mass immunization programs. Major trends in the forecast period include increasing adoption of auto-disable and safety-engineered syringes, rising integration of dose accuracy monitoring features, growing focus on needlestick injury prevention, expansion of smart drug delivery solutions, enhanced emphasis on infection control compliance.
Increasing healthcare expenditure is anticipated to drive the growth of the smart syringes market in the coming years. Healthcare expenditure represents the total resources, usually quantified in monetary terms, that a country, organization, or individual dedicates to healthcare services and products. This rise in spending is influenced by various factors, including an aging population, the prevalence of chronic diseases, advancements in medical technology, and growing consumer expectations for high-quality care. The smart syringes market aligns with this increased expenditure by offering innovative solutions that enhance patient safety, improve procedural efficiency, and lower healthcare costs related to complications from traditional syringes. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization, projected total health spending in Canada to reach $344 billion for the year, a 2.8% increase over the prior year. Thus, the growth in healthcare expenditure is fueling the expansion of the smart syringes market.
Major companies operating in the smart syringe market are emphasizing the development of advanced, safety-enhanced injection solutions to improve patient protection, reduce needlestick injuries, and strengthen infection control in clinical settings. These innovations typically incorporate automated or built-in safety features designed to minimize accidental exposure to blood-borne pathogens while improving procedural efficiency for healthcare professionals. For example, in April 2024, Hindustan Syringes and Medical Devices, an India-based medical devices company, introduced Dispojekt Syringes, an advanced safety syringe designed to substantially reduce the occurrence of accidental needlestick injuries among medical staff. The syringe includes a transparent, one-hand-operable safety mechanism and a molded plastic safety shield that prevents blood splatter during use, enhancing both ease of use and workplace safety. By addressing key occupational and patient safety challenges, Dispojekt underscores HMD’s commitment to technological innovation and aligns with India’s broader objective of strengthening its presence in global medical device manufacturing.
In June 2025, Flat Medical, a Taiwan-based provider of smart procedural safety devices for anesthesia and pain management, partnered with Mercury Medical to broaden U.S. access to its EpiFaith smart syringe technology. Through this partnership, Flat Medical aims to accelerate nationwide adoption of its intelligent epidural placement system by leveraging Mercury Medical’s established distribution network and clinical presence. Mercury Medical is a US-based provider of airway management, anesthesia, and critical care equipment serving hospitals, surgery centers, and emergency care settings.
Major companies operating in the smart syringe market are Becton Dickinson and Company, Terumo Corporation, B Braun Melsungen AG, Gerresheimer AG, Retractable Technologies Inc., Nipro Corporation, Sharps Technology, Revolutions Medical Corporation, Owen Mumford Ltd., Ypsomed Holding AG, Weigao Group, Shandong Weigao Group Medical Polymer Co Ltd, Jiangsu Huida Medical Instruments Co Ltd, Numedico Technologies Pty Ltd, AdvaCare Pharma, Star Syringe Ltd, Hindustan Syringes And Medical Devices Ltd, Albert David Ltd, Vitromed Healthcare, Iscon Surgicals Ltd.
North America was the largest region in the global smart syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart syringe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the smart syringe market by increasing costs of imported medical-grade plastics, precision molding tools, safety mechanisms, and embedded electronic components. Healthcare providers in North America and Europe are most affected due to dependence on imported syringe components, while Asia-Pacific faces pricing pressure on large-scale manufacturing exports. These tariffs are increasing unit costs and procurement expenses for hospitals. At the same time, they are supporting domestic syringe manufacturing, local material sourcing, and regional production scale-up of safety-engineered syringes.
The smart syringe market research report is one of a series of new reports that provides smart syringe market statistics, including smart syringe industry global market size, regional shares, competitors with a smart syringe market share, detailed smart syringe market segments, market trends and opportunities, and any further data you may need to thrive in the smart syringe industry. This smart syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Smart syringes represent cutting-edge medical devices that integrate technology to enhance the safety, precision, and efficiency of administering injections. These innovative syringes effectively address critical concerns such as needlestick injuries, medication errors, and the transmission of bloodborne diseases, thereby significantly improving both patient and healthcare provider safety.
The primary categories of smart syringes include auto-disable syringes, active safety syringes, and passive safety syringes. Auto-disable syringes are specifically engineered to prevent reuse after a single injection. Widely employed in immunization campaigns, these syringes automatically lock after a single use, ensuring the secure and contamination-free delivery of doses. This versatile solution caters to various segments, including pediatrics and adults, and finds applications in drug delivery, vaccination, and blood specimen collection. Auto-disable syringes are utilized across diverse industries, including hospitals, health maintenance organizations (HMOs), diabetic patient care, family practices (physicians), psychiatry, and more.
The smart syringes market consists of sales of exchangeable needle syringes and fixed needle syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The smart syringe market size is expected to see rapid growth in the next few years. It will grow to $21.46 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand for smart drug administration devices, rising government mandates for safety syringes, expansion of home-based healthcare delivery, growing focus on digital medication tracking, increasing adoption in mass immunization programs. Major trends in the forecast period include increasing adoption of auto-disable and safety-engineered syringes, rising integration of dose accuracy monitoring features, growing focus on needlestick injury prevention, expansion of smart drug delivery solutions, enhanced emphasis on infection control compliance.
Increasing healthcare expenditure is anticipated to drive the growth of the smart syringes market in the coming years. Healthcare expenditure represents the total resources, usually quantified in monetary terms, that a country, organization, or individual dedicates to healthcare services and products. This rise in spending is influenced by various factors, including an aging population, the prevalence of chronic diseases, advancements in medical technology, and growing consumer expectations for high-quality care. The smart syringes market aligns with this increased expenditure by offering innovative solutions that enhance patient safety, improve procedural efficiency, and lower healthcare costs related to complications from traditional syringes. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization, projected total health spending in Canada to reach $344 billion for the year, a 2.8% increase over the prior year. Thus, the growth in healthcare expenditure is fueling the expansion of the smart syringes market.
Major companies operating in the smart syringe market are emphasizing the development of advanced, safety-enhanced injection solutions to improve patient protection, reduce needlestick injuries, and strengthen infection control in clinical settings. These innovations typically incorporate automated or built-in safety features designed to minimize accidental exposure to blood-borne pathogens while improving procedural efficiency for healthcare professionals. For example, in April 2024, Hindustan Syringes and Medical Devices, an India-based medical devices company, introduced Dispojekt Syringes, an advanced safety syringe designed to substantially reduce the occurrence of accidental needlestick injuries among medical staff. The syringe includes a transparent, one-hand-operable safety mechanism and a molded plastic safety shield that prevents blood splatter during use, enhancing both ease of use and workplace safety. By addressing key occupational and patient safety challenges, Dispojekt underscores HMD’s commitment to technological innovation and aligns with India’s broader objective of strengthening its presence in global medical device manufacturing.
In June 2025, Flat Medical, a Taiwan-based provider of smart procedural safety devices for anesthesia and pain management, partnered with Mercury Medical to broaden U.S. access to its EpiFaith smart syringe technology. Through this partnership, Flat Medical aims to accelerate nationwide adoption of its intelligent epidural placement system by leveraging Mercury Medical’s established distribution network and clinical presence. Mercury Medical is a US-based provider of airway management, anesthesia, and critical care equipment serving hospitals, surgery centers, and emergency care settings.
Major companies operating in the smart syringe market are Becton Dickinson and Company, Terumo Corporation, B Braun Melsungen AG, Gerresheimer AG, Retractable Technologies Inc., Nipro Corporation, Sharps Technology, Revolutions Medical Corporation, Owen Mumford Ltd., Ypsomed Holding AG, Weigao Group, Shandong Weigao Group Medical Polymer Co Ltd, Jiangsu Huida Medical Instruments Co Ltd, Numedico Technologies Pty Ltd, AdvaCare Pharma, Star Syringe Ltd, Hindustan Syringes And Medical Devices Ltd, Albert David Ltd, Vitromed Healthcare, Iscon Surgicals Ltd.
North America was the largest region in the global smart syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart syringe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the smart syringe market by increasing costs of imported medical-grade plastics, precision molding tools, safety mechanisms, and embedded electronic components. Healthcare providers in North America and Europe are most affected due to dependence on imported syringe components, while Asia-Pacific faces pricing pressure on large-scale manufacturing exports. These tariffs are increasing unit costs and procurement expenses for hospitals. At the same time, they are supporting domestic syringe manufacturing, local material sourcing, and regional production scale-up of safety-engineered syringes.
The smart syringe market research report is one of a series of new reports that provides smart syringe market statistics, including smart syringe industry global market size, regional shares, competitors with a smart syringe market share, detailed smart syringe market segments, market trends and opportunities, and any further data you may need to thrive in the smart syringe industry. This smart syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Smart syringes represent cutting-edge medical devices that integrate technology to enhance the safety, precision, and efficiency of administering injections. These innovative syringes effectively address critical concerns such as needlestick injuries, medication errors, and the transmission of bloodborne diseases, thereby significantly improving both patient and healthcare provider safety.
The primary categories of smart syringes include auto-disable syringes, active safety syringes, and passive safety syringes. Auto-disable syringes are specifically engineered to prevent reuse after a single injection. Widely employed in immunization campaigns, these syringes automatically lock after a single use, ensuring the secure and contamination-free delivery of doses. This versatile solution caters to various segments, including pediatrics and adults, and finds applications in drug delivery, vaccination, and blood specimen collection. Auto-disable syringes are utilized across diverse industries, including hospitals, health maintenance organizations (HMOs), diabetic patient care, family practices (physicians), psychiatry, and more.
The smart syringes market consists of sales of exchangeable needle syringes and fixed needle syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Smart Syringe Market Characteristics
3. Smart Syringe Market Supply Chain Analysis
4. Global Smart Syringe Market Trends and Strategies
5. Smart Syringe Market Analysis of End Use Industries
7. Global Smart Syringe Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Smart Syringe Total Addressable Market (TAM) Analysis for the Market
9. Smart Syringe Market Segmentation
10. Smart Syringe Market Regional and Country Analysis
11. Asia-Pacific Smart Syringe Market
12. China Smart Syringe Market
13. India Smart Syringe Market
14. Japan Smart Syringe Market
15. Australia Smart Syringe Market
16. Indonesia Smart Syringe Market
17. South Korea Smart Syringe Market
18. Taiwan Smart Syringe Market
19. South East Asia Smart Syringe Market
20. Western Europe Smart Syringe Market
21. UK Smart Syringe Market
22. Germany Smart Syringe Market
23. France Smart Syringe Market
24. Italy Smart Syringe Market
25. Spain Smart Syringe Market
26. Eastern Europe Smart Syringe Market
27. Russia Smart Syringe Market
28. North America Smart Syringe Market
29. USA Smart Syringe Market
30. Canada Smart Syringe Market
31. South America Smart Syringe Market
32. Brazil Smart Syringe Market
33. Middle East Smart Syringe Market
34. Africa Smart Syringe Market
36. Smart Syringe Market Competitive Landscape and Company Profiles
37. Smart Syringe Market Other Major and Innovative Companies
40. Smart Syringe Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Smart Syringe Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses smart syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for smart syringe? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart syringe market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Auto-Disable Syringes; Active Safety Syringes; Passive Safety Syringes2) By Age Group: Pediatrics; Adults
3) By Application: Drug Delivery; Vaccination
4) By End Users: Hospitals And Health Maintenance Organizations (HMOs); Diabetic Patients; Family Practices
Subsegments:
1) By Auto-Disable Syringes: Fixed-Dose Auto-Disable Syringes; Variable-Dose Auto-Disable Syringes; Low Dead Space Auto-Disable Syringes2) By Active Safety Syringes: Retractable Needle Syringes; Shielded Needle Syringes
3) By Passive Safety Syringes: Integrated Safety Mechanism Syringes; Clamshell Safety Syringes
Companies Mentioned: Becton Dickinson and Company; Terumo Corporation; B Braun Melsungen AG; Gerresheimer AG; Retractable Technologies Inc.; Nipro Corporation; Sharps Technology; Revolutions Medical Corporation; Owen Mumford Ltd.; Ypsomed Holding AG; Weigao Group; Shandong Weigao Group Medical Polymer Co Ltd; Jiangsu Huida Medical Instruments Co Ltd; Numedico Technologies Pty Ltd; AdvaCare Pharma; Star Syringe Ltd; Hindustan Syringes And Medical Devices Ltd; Albert David Ltd; Vitromed Healthcare; Iscon Surgicals Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Smart Syringe market report include:- Becton Dickinson and Company
- Terumo Corporation
- B Braun Melsungen AG
- Gerresheimer AG
- Retractable Technologies Inc.
- Nipro Corporation
- Sharps Technology
- Revolutions Medical Corporation
- Owen Mumford Ltd.
- Ypsomed Holding AG
- Weigao Group
- Shandong Weigao Group Medical Polymer Co Ltd
- Jiangsu Huida Medical Instruments Co Ltd
- Numedico Technologies Pty Ltd
- AdvaCare Pharma
- Star Syringe Ltd
- Hindustan Syringes And Medical Devices Ltd
- Albert David Ltd
- Vitromed Healthcare
- Iscon Surgicals Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 13.55 Billion |
| Forecasted Market Value ( USD | $ 21.46 Billion |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
